Clal Insurance’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.5M | Buy |
|
|||||
|
2025
Q1 | $20.6M | Sell |
|
|||||
|
2024
Q4 | $48.1M | Sell |
|
|||||
|
2024
Q3 | $141M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $26.1M | Hold |
|
|||||
|
2023
Q2 | $29.7M | Sell |
|
|||||
|
2023
Q1 | $50.8M | Sell |
|
|||||
|
2022
Q4 | $131M | Hold |
|
|||||
|
2022
Q3 | $125M | Sell |
|
|||||
|
2022
Q2 | $181M | Buy |
|
|||||
|
2022
Q1 | $182M | Buy |
|
|||||
|
2021
Q4 | $94.9M | Buy |
|
|||||
|
2021
Q3 | $71.8M | Buy |
|
|||||
|
2021
Q2 | $62.3M | Buy |
|
|||||
|
2021
Q1 | $25.8M | Sell |
|
|||||
|
2020
Q4 | $68.9M | Sell |
|
|||||
|
2020
Q3 | $74.7M | Hold |
|
|||||
|
2020
Q2 | $75M | Sell |
|
|||||
|
2020
Q1 | $72.4M | Buy |
|
|||||
|
2019
Q4 | $634K | Sell |
|
|||||
|
2019
Q3 | $71.2M | Hold |
|
|||||
|
2019
Q2 | $81.9M | Buy |
|
|||||
|
2019
Q1 | $84.5M | Buy |
|
|||||
|
2018
Q4 | $43M | Hold |
|
|||||
|
2018
Q3 | $57.5M | Hold |
|
|||||
|
2018
Q2 | $57.1M | Sell |
|
|||||
|
2018
Q1 | $119M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $7.43M | Hold |
|
|||||
|
2016
Q3 | $8.32M | Buy |
|